I Cashed Out Of Oracle For +50%, Now I'm Buying Back In (Rating Upgrade)

Oracle was upgraded to Strong Buy after a 30% price correction, with a 12-month price target of $330. Q4 revenue grew 21% and cloud revenue rose 47%, but heavy AI capex pushed FY26 free cash flow negative. Despite leverage, dilution, and capex intensity risks, the note argues the lower valuation and forward PEG now offer attractive value.

Analysis

The market is starting to separate ORCL’s operating leverage from its capital intensity, and that creates a more interesting setup than a simple post-correction value trade. The near-term winners are AI infrastructure buyers that can offload capex onto vendors’ balance sheets, while the losers are more likely to be long-duration equity holders who underestimate how much free cash flow can stay impaired even as revenue growth stays healthy. If Oracle keeps winning large AI workloads, the second-order effect is pressure on legacy software peers to justify their own cloud and AI spend without the same scale advantages.

The key risk is that this becomes a “good business, bad stock” story for longer than expected: earnings can look fine while FCF and dilution keep suppressing multiple expansion. Over the next 1-2 quarters, the stock likely trades on guidance quality and capex cadence rather than headline growth; over 12 months, the setup improves only if capex growth inflects lower or management shows a credible path to positive FCF conversion. If that doesn’t happen, the re-rating can stall even with strong top-line momentum.

Consensus appears to be anchoring on growth and underweighting the financing burden of that growth. The contrarian view is that the selloff may have already priced in a lot of the balance-sheet anxiety, so the asymmetry is better than it looks if AI demand stays scarce and strategic customers keep paying up for capacity. But because the stock is now a leverage-to-growth story, any slowdown in bookings or a single guidance miss could trigger a sharp de-rating over days rather than months.

Key Decisions for Investors

• Long ORCL on weakness over the next 1-2 weeks, with a 6-12 month horizon; the setup is attractive if you believe revenue can keep compounding faster than capex, but size modestly because FCF remains the key overhang.
• Use a call spread in ORCL (3-6 month tenor) instead of outright stock to express upside while limiting downside to a renewed capex scare; best if implied volatility remains elevated after the re-rating.
• Pair trade: long ORCL / short a higher-valuation cloud/software peer with similar AI spend exposure but weaker growth quality, targeting a 3-6 month relative-value move if investors continue rewarding revenue growth over near-term cash burn.
• If ORCL gaps higher on any guidance beat, take partial profits into strength; the stock is vulnerable to a multiple pause until management proves FCF conversion can normalize.
• Set a hard risk trigger on any quarter showing accelerating dilution plus unchanged capex intensity; that combination would likely invalidate the bullish thesis within one reporting cycle.